<?xml version="1.0" encoding="UTF-8"?>
<dokument xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="https://lovdata.no/regelverk" xsi:schemaLocation="lov-eksempel.xsd" id="for-2016-10-11-1279" type="lt" url="https://lovdata.no/lovtidend/forskrift/2016-10-11-1279">
  <metadata>
    <type>lt</type>
    <base>LT</base>
    <id>LT/lt/2016-10-11-1279</id>
    <dato>11.10.2016 nr. 1279</dato>
    <dato type="iso">2016-10-11</dato>
    <publisert>I 2016 hefte 14 s 2288</publisert>
    <ikraft>15.11.2016</ikraft>
    <ikraft type="iso">2016-11-15</ikraft>
    <departement>Helse- og omsorgsdepartementet</departement>
    <etat/>
    <gjelder>Norge</gjelder>
    <hjemmel><ref id="for-2015-06-12-646-§3">F12.06.2015 nr. 646 § 3</ref>, <ref id="for-2015-06-26-1153">F26.06.2015 nr. 1153</ref>, <ref id="lov-2014-06-20-42-§11">L20.06.2014 nr. 42 § 11</ref>, <ref id="lov-2014-06-20-42-§12">§ 12</ref>, <ref id="lov-2014-06-20-42-§14">§ 14</ref>, <ref id="lov-1992-12-04-132-§25b">L04.12.1992 nr. 132 § 25b</ref>,</hjemmel>
    <endrer type="ref">https://lovdata.no/for/2015-06-12-646</endrer>
    <rettet/>
    <journalnummer>2016-1047</journalnummer>
  </metadata>
  <tekst>
    <korttittel>Endr. i forskrift om helseforetaksfinansierte reseptlegemidler</korttittel>
    <korttittel>4 Endr. i forskrift om helseforetaksfinansierte reseptlegemidler til bruk utenfor sykehus (Nr. 1279)</korttittel>
    <tittel>Forskrift om endring i forskrift om helseforetaksfinansierte reseptlegemidler til bruk utenfor sykehus</tittel>
    <redaksjonell_note><b>Hjemmel:</b> Fastsatt av Helsedirektoratet 11. oktober 2016 med hjemmel i forskrift 12. juni 2015 nr. 646 om helseforetaksfinansierte reseptlegemidler til bruk utenfor sykehus § 3, jf. delegeringsvedtak 26. juni 2015 nr. 1153.</redaksjonell_note>
    <kapittel type="kapittel" id="/kapittel/i" url="https://lovdata.no/lovtidend/forskrift/2016-10-11-1279/ki">
      <kverdi>I</kverdi>
      <ktittel/>
      <ledd id="/kapittel/i/ledd/1">I forskrift 12. juni 2015 nr. 646 om helseforetaksfinansierte reseptlegemidler til bruk utenfor sykehus gjøres følgende endring:
<br/></ledd>
      <ledd id="/kapittel/i/ledd/2">Liste over legemidler som skal finansieres av de regionale helseforetakene skal lyde:</ledd>
      <table niv="1" frame="1">
        <thgroup cols="5" rowsep="0" colsep="0">
          <colspec colname="1" align="left" valign="top" colwidth="14*"/>
          <colspec colname="2" align="left" valign="top" colwidth="18*"/>
          <colspec colname="3" align="left" valign="top" colwidth="12*"/>
          <colspec colname="4" align="left" valign="top" colwidth="20*"/>
          <colspec colname="5" align="center" valign="top" colwidth="12*"/>
          <tbody>
            <row>
              <entry colname="1">
                <i>Preparatnavn</i>
              </entry>
              <entry colname="2">
                <i>Virkestoff</i>
              </entry>
              <entry colname="3">
                <i>ATC-kode</i>
              </entry>
              <entry colname="4">
                <i>Bruksområde</i>
              </entry>
              <entry colname="5">
                <i>Overføringsdato</i>
              </entry>
            </row>
          </tbody>
        </thgroup>
        <tgroup cols="5" rowsep="0" colsep="0">
          <colspec colname="1" align="left" valign="top" colwidth="14*"/>
          <colspec colname="2" align="left" valign="top" colwidth="18*"/>
          <colspec colname="3" align="left" valign="top" colwidth="12*"/>
          <colspec colname="4" align="left" valign="top" colwidth="20*"/>
          <colspec colname="5" align="center" valign="top" colwidth="12*"/>
          <tbody>
            <row>
              <entry colname="1">Riastap </entry>
              <entry colname="2">Humant fibrinogen </entry>
              <entry colname="3">B02BB01 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Confidex </entry>
              <entry colname="2">Koagulasjonsfaktor II, VII, IX og X i kombinasjon </entry>
              <entry colname="3">B02BD01 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Octaplex </entry>
              <entry colname="2">Koagulasjonsfaktor II, VII, IX og X i kombinasjon </entry>
              <entry colname="3">B02BD01 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Prothromplex </entry>
              <entry colname="2">Koagulasjonsfaktor II, VII, IX og X i kombinasjon </entry>
              <entry colname="3">B02BD01 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Advate </entry>
              <entry colname="2">Koagulasjonsfaktor VIII </entry>
              <entry colname="3">B02BD02 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Afstyla </entry>
              <entry colname="2">Koagulasjonsfaktor VIII </entry>
              <entry colname="3">B02BD02 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">15.11.2016 </entry>
            </row>
            <row>
              <entry colname="1">Elocta </entry>
              <entry colname="2">Koagulasjonsfaktor VIII </entry>
              <entry colname="3">B02BD02 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">15.04.2016 </entry>
            </row>
            <row>
              <entry colname="1">Helixate NexGen </entry>
              <entry colname="2">Koagulasjonsfaktor VIII </entry>
              <entry colname="3">B02BD02 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Iblias </entry>
              <entry colname="2">Koagulasjonsfaktor VIII </entry>
              <entry colname="3">B02BD02 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">15.04.2016 </entry>
            </row>
            <row>
              <entry colname="1">Kogenate </entry>
              <entry colname="2">Koagulasjonsfaktor VIII </entry>
              <entry colname="3">B02BD02 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Kovaltry </entry>
              <entry colname="2">Koagulasjonsfaktor VIII </entry>
              <entry colname="3">B02BD02 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">15.04.2016 </entry>
            </row>
            <row>
              <entry colname="1">NovoEight </entry>
              <entry colname="2">Koagulasjonsfaktor VIII </entry>
              <entry colname="3">B02BD02 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Nuwiq </entry>
              <entry colname="2">Koagulasjonsfaktor VIII </entry>
              <entry colname="3">B02BD02 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Octanate </entry>
              <entry colname="2">Koagulasjonsfaktor VIII </entry>
              <entry colname="3">B02BD02 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">ReFacto AF </entry>
              <entry colname="2">Koagulasjonsfaktor VIII </entry>
              <entry colname="3">B02BD02 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Feiba </entry>
              <entry colname="2">Faktor VIII-inhibitor bypass-aktivitet </entry>
              <entry colname="3">B02BD03 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Alprolix </entry>
              <entry colname="2">Koagulasjonsfaktor IX </entry>
              <entry colname="3">B02BD04 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">15.04.2016 </entry>
            </row>
            <row>
              <entry colname="1">Idelvion </entry>
              <entry colname="2">Koagulasjonsfaktor IX </entry>
              <entry colname="3">B02BD04 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">15.05.2016 </entry>
            </row>
            <row>
              <entry colname="1">Immunine </entry>
              <entry colname="2">Koagulasjonsfaktor IX </entry>
              <entry colname="3">B02BD04 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Octanine </entry>
              <entry colname="2">Koagulasjonsfaktor IX </entry>
              <entry colname="3">B02BD04 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Rixubis </entry>
              <entry colname="2">Koagulasjonsfaktor IX </entry>
              <entry colname="3">B02BD04 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">15.04.2016 </entry>
            </row>
            <row>
              <entry colname="1"/>
              <entry colname="2">Koagulasjonsfaktor IX (nonakog beta pegol) </entry>
              <entry colname="3">B02BD04 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">15.11.2016 </entry>
            </row>
            <row>
              <entry colname="1">Haemate </entry>
              <entry colname="2">Von Willebrands faktor og koagulasjonsfaktor VIII i kombinasjon </entry>
              <entry colname="3">B02BD06 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Voncento </entry>
              <entry colname="2">Von Willebrands faktor og koagulasjonsfaktor VIII i kombinasjon </entry>
              <entry colname="3">B02BD06 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">15.04.2016 </entry>
            </row>
            <row>
              <entry colname="1">Wilate </entry>
              <entry colname="2">Von Willebrands faktor og koagulasjonsfaktor VIII i kombinasjon </entry>
              <entry colname="3">B02BD06 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Cluvot </entry>
              <entry colname="2">Koagulasjonsfaktor XIII </entry>
              <entry colname="3">B02BD07 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">NovoSeven </entry>
              <entry colname="2">Eptacog alfa (aktivert) </entry>
              <entry colname="3">B02BD08 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">BeneFix </entry>
              <entry colname="2">Nonacog alfa </entry>
              <entry colname="3">B02BD09 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Willfact 1000 IE </entry>
              <entry colname="2">Von Willebrands faktor </entry>
              <entry colname="3">B02BD10 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">NovoThirteen </entry>
              <entry colname="2">Katridekakog </entry>
              <entry colname="3">B02BD11 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Coagadex </entry>
              <entry colname="2">Koagulasjonsfaktor X </entry>
              <entry colname="3">B02BD13 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">15.07.2016 </entry>
            </row>
            <row>
              <entry colname="1">Obizur </entry>
              <entry colname="2">Koagulasjonsfaktor VIII </entry>
              <entry colname="3">B02BD14 </entry>
              <entry colname="4">Blodkoagulasjonsfaktorer </entry>
              <entry colname="5">15.04.2016 </entry>
            </row>
            <row>
              <entry colname="1">Eporatio </entry>
              <entry colname="2">Erytropoietin </entry>
              <entry colname="3">B03XA01 </entry>
              <entry colname="4">Anemilegemidler </entry>
              <entry colname="5">15.10.2016 </entry>
            </row>
            <row>
              <entry colname="1">Eprex </entry>
              <entry colname="2">Erytropoietin </entry>
              <entry colname="3">B03XA01 </entry>
              <entry colname="4">Anemilegemidler </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">NeoRecormon </entry>
              <entry colname="2">Erytropoietin </entry>
              <entry colname="3">B03XA01 </entry>
              <entry colname="4">Anemilegemidler </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Retacrit </entry>
              <entry colname="2">Erytropoietin </entry>
              <entry colname="3">B03XA01 </entry>
              <entry colname="4">Anemilegemidler </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Aranesp </entry>
              <entry colname="2">Darbepoetin alfa </entry>
              <entry colname="3">B03XA02 </entry>
              <entry colname="4">Anemilegemidler </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Mircera </entry>
              <entry colname="2">Metoksypolyetylen-glykol-epoetin beta </entry>
              <entry colname="3">B03XA03 </entry>
              <entry colname="4">Anemilegemidler </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Genotropin </entry>
              <entry colname="2">Somatropin </entry>
              <entry colname="3">H01AC01 </entry>
              <entry colname="4">Veksthormoner </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Humatrope </entry>
              <entry colname="2">Somatropin </entry>
              <entry colname="3">H01AC01 </entry>
              <entry colname="4">Veksthormoner </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Norditropin NordiFlex </entry>
              <entry colname="2">Somatropin </entry>
              <entry colname="3">H01AC01 </entry>
              <entry colname="4">Veksthormoner </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Norditropin SimpleXx </entry>
              <entry colname="2">Somatropin </entry>
              <entry colname="3">H01AC01 </entry>
              <entry colname="4">Veksthormoner </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">NutropinAq </entry>
              <entry colname="2">Somatropin </entry>
              <entry colname="3">H01AC01 </entry>
              <entry colname="4">Veksthormoner </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Omnitrope </entry>
              <entry colname="2">Somatropin </entry>
              <entry colname="3">H01AC01 </entry>
              <entry colname="4">Veksthormoner </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Saizen </entry>
              <entry colname="2">Somatropin </entry>
              <entry colname="3">H01AC01 </entry>
              <entry colname="4">Veksthormoner </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Zomacton </entry>
              <entry colname="2">Somatropin </entry>
              <entry colname="3">H01AC01 </entry>
              <entry colname="4">Veksthormoner </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Increlex </entry>
              <entry colname="2">Mecasermin </entry>
              <entry colname="3">H01AC03 </entry>
              <entry colname="4">Veksthormoner </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Olysio </entry>
              <entry colname="2">Simeprevir </entry>
              <entry colname="3">J05AE14 </entry>
              <entry colname="4">Hepatitt C </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Daklinza </entry>
              <entry colname="2">Daklatasvir </entry>
              <entry colname="3">J05AX14 </entry>
              <entry colname="4">Hepatitt C </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Sovaldi </entry>
              <entry colname="2">Sofosbuvir </entry>
              <entry colname="3">J05AX15 </entry>
              <entry colname="4">Hepatitt C </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Exviera </entry>
              <entry colname="2">Dasabuvir </entry>
              <entry colname="3">J05AX16 </entry>
              <entry colname="4">Hepatitt C </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Harvoni </entry>
              <entry colname="2">Sofosbuvir og ledipasvir </entry>
              <entry colname="3">J05AX65 </entry>
              <entry colname="4">Hepatitt C </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Viekirax </entry>
              <entry colname="2">Ombitasvir, paritaprevir og ritonavir </entry>
              <entry colname="3">J05AX67 </entry>
              <entry colname="4">Hepatitt C </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Zepatier </entry>
              <entry colname="2">Elbasvir/grazoprevir </entry>
              <entry colname="3">J05AX68 </entry>
              <entry colname="4">Hepatitt C </entry>
              <entry colname="5">15.05.2016 </entry>
            </row>
            <row>
              <entry colname="1">Epclusa </entry>
              <entry colname="2">Sofosbuvir/Velpatasvir </entry>
              <entry colname="3">J05AX </entry>
              <entry colname="4">Hepatitt C </entry>
              <entry colname="5">15.07.2016 </entry>
            </row>
            <row>
              <entry colname="1">Herceptin </entry>
              <entry colname="2">Trastuzumab </entry>
              <entry colname="3">L01XC03 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.07.2014 </entry>
            </row>
            <row>
              <entry colname="1">Zelboraf </entry>
              <entry colname="2">Vemurafenib </entry>
              <entry colname="3">L01XE15 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.01.2014 </entry>
            </row>
            <row>
              <entry colname="1">Tafinlar </entry>
              <entry colname="2">Dabrafenib </entry>
              <entry colname="3">L01XE23 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.01.2014 </entry>
            </row>
            <row>
              <entry colname="1">Mekinist </entry>
              <entry colname="2">Trametinib </entry>
              <entry colname="3">L01XE25 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.07.2014 </entry>
            </row>
            <row>
              <entry colname="1">Imbruvica </entry>
              <entry colname="2">Ibrutinib </entry>
              <entry colname="3">L01XE27 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.07.2015 </entry>
            </row>
            <row>
              <entry colname="1">Vargatef </entry>
              <entry colname="2">Nintedanib </entry>
              <entry colname="3">L01XE31 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.04.2015 </entry>
            </row>
            <row>
              <entry colname="1">Zemfirza </entry>
              <entry colname="2">Cediranib </entry>
              <entry colname="3">L01XE32 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.11.2016 </entry>
            </row>
            <row>
              <entry colname="1">Tagrisso </entry>
              <entry colname="2">Osinertinib </entry>
              <entry colname="3">L01XE35 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.05.2016 </entry>
            </row>
            <row>
              <entry colname="1">Cotellic </entry>
              <entry colname="2">Cobimetinib </entry>
              <entry colname="3">L01XE38 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.12.2015 </entry>
            </row>
            <row>
              <entry colname="1">Graspa </entry>
              <entry colname="2">Eryaspase </entry>
              <entry colname="3">L01XX02 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.11.2016 </entry>
            </row>
            <row>
              <entry colname="1">Lynparza </entry>
              <entry colname="2">Olaparib </entry>
              <entry colname="3">L01XX46 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.07.2015 </entry>
            </row>
            <row>
              <entry colname="1">Zydelig </entry>
              <entry colname="2">Idelalisib </entry>
              <entry colname="3">L01XX47 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.07.2015 </entry>
            </row>
            <row>
              <entry colname="1">Ninlaro </entry>
              <entry colname="2">Ixazomib </entry>
              <entry colname="3">L01XX50 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.05.2016 </entry>
            </row>
            <row>
              <entry colname="1">Venetoclax </entry>
              <entry colname="2">Venetoclax </entry>
              <entry colname="3">L01XX52 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">15.07.2016 </entry>
            </row>
            <row>
              <entry colname="1">Xtandi </entry>
              <entry colname="2">Enzalutamid </entry>
              <entry colname="3">L02BB04 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.01.2014 </entry>
            </row>
            <row>
              <entry colname="1">Zytiga </entry>
              <entry colname="2">Abirateronacetat </entry>
              <entry colname="3">L02BX03 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.01.2014 </entry>
            </row>
            <row>
              <entry colname="1">Bondronat </entry>
              <entry colname="2">Ibandronsyre </entry>
              <entry colname="3">M05BA06 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.01.2009 </entry>
            </row>
            <row>
              <entry colname="1">Xgeva </entry>
              <entry colname="2">Denosumab </entry>
              <entry colname="3">M05BX04 </entry>
              <entry colname="4">Kreftsykdommer </entry>
              <entry colname="5">01.01.2014 </entry>
            </row>
            <row>
              <entry colname="1">Neupogen </entry>
              <entry colname="2">Filgrastim </entry>
              <entry colname="3">L03AA02 </entry>
              <entry colname="4">Immunstimulerende legemidler </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Nivestim </entry>
              <entry colname="2">Filgrastim </entry>
              <entry colname="3">L03AA02 </entry>
              <entry colname="4">Immunstimulerende legemidler </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Tevagrastim </entry>
              <entry colname="2">Filgrastim </entry>
              <entry colname="3">L03AA02 </entry>
              <entry colname="4">Immunstimulerende legemidler </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Zarzio </entry>
              <entry colname="2">Filgrastim </entry>
              <entry colname="3">L03AA02 </entry>
              <entry colname="4">Immunstimulerende legemidler </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Efgratin </entry>
              <entry colname="2">Pegfilgrastim </entry>
              <entry colname="3">L03AA13 </entry>
              <entry colname="4">Immunstimulerende legemidler </entry>
              <entry colname="5">15.10.2016 </entry>
            </row>
            <row>
              <entry colname="1">Neulasta </entry>
              <entry colname="2">Pegfilgrastim </entry>
              <entry colname="3">L03AA13 </entry>
              <entry colname="4">Immunstimulerende legemidler </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Pegfilgrastim Stada </entry>
              <entry colname="2">Pegfilgrastim </entry>
              <entry colname="3">L03AA13 </entry>
              <entry colname="4">Immunstimulerende legemidler </entry>
              <entry colname="5">15.10.2016 </entry>
            </row>
            <row>
              <entry colname="1">Ristempa </entry>
              <entry colname="2">Pegfilgrastim </entry>
              <entry colname="3">L03AA13 </entry>
              <entry colname="4">Immunstimulerende legemidler </entry>
              <entry colname="5">15.10.2016 </entry>
            </row>
            <row>
              <entry colname="1">Zioxtenzo </entry>
              <entry colname="2">Pegfilgrastim </entry>
              <entry colname="3">L03AA13 </entry>
              <entry colname="4">Immunstimulerende legemidler </entry>
              <entry colname="5">15.10.2016 </entry>
            </row>
            <row>
              <entry colname="1">Lonquex </entry>
              <entry colname="2">Lipefilgrastim </entry>
              <entry colname="3">L03AA14 </entry>
              <entry colname="4">Immunstimulerende legemidler </entry>
              <entry colname="5">01.01.2016 </entry>
            </row>
            <row>
              <entry colname="1">Avonex </entry>
              <entry colname="2">Interferon beta-1a </entry>
              <entry colname="3">L03AB07 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">01.01.2008 </entry>
            </row>
            <row>
              <entry colname="1">Rebif </entry>
              <entry colname="2">Interferon beta-1a </entry>
              <entry colname="3">L03AB07 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">01.01.2008 </entry>
            </row>
            <row>
              <entry colname="1">Betaferon </entry>
              <entry colname="2">Interferon beta-1b </entry>
              <entry colname="3">L03AB08 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">01.01.2008 </entry>
            </row>
            <row>
              <entry colname="1">Extavia </entry>
              <entry colname="2">Interferon beta-1b </entry>
              <entry colname="3">L03AB08 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">01.01.2008 </entry>
            </row>
            <row>
              <entry colname="1">Plegridy </entry>
              <entry colname="2">Peginterferon beta-1a </entry>
              <entry colname="3">L03AB13 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">01.12.2014 </entry>
            </row>
            <row>
              <entry colname="1">Copaxone </entry>
              <entry colname="2">Glatirameracetat </entry>
              <entry colname="3">L03AX13 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">01.01.2008 </entry>
            </row>
            <row>
              <entry colname="1">Zinbryta </entry>
              <entry colname="2">Dalizumab </entry>
              <entry colname="3">L04AA08 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">15.05.2016 </entry>
            </row>
            <row>
              <entry colname="1">Gilenya </entry>
              <entry colname="2">Fingolimod </entry>
              <entry colname="3">L04AA27 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">15.07.2011 </entry>
            </row>
            <row>
              <entry colname="1">Aubagio </entry>
              <entry colname="2">Teriflunomid </entry>
              <entry colname="3">L04AA31 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">01.10.2013 </entry>
            </row>
            <row>
              <entry colname="1">Lemtrada </entry>
              <entry colname="2">Alemtuzumab </entry>
              <entry colname="3">L04AA34 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">01.10.2013 </entry>
            </row>
            <row>
              <entry colname="1">Tecfidera </entry>
              <entry colname="2">Dimetylfumarat </entry>
              <entry colname="3">N07XX09 </entry>
              <entry colname="4">Multippel sklerose </entry>
              <entry colname="5">01.10.2013 </entry>
            </row>
            <row>
              <entry colname="1">MabThera </entry>
              <entry colname="2">Rituksimab </entry>
              <entry colname="3">L01XC02 </entry>
              <entry colname="4">Revmatologiske- og kreftsykdommer </entry>
              <entry colname="5">01.07.2014 </entry>
            </row>
            <row>
              <entry colname="1">Orencia </entry>
              <entry colname="2">Abatacept </entry>
              <entry colname="3">L04AA24 </entry>
              <entry colname="4">Revmatologiske sykdommer </entry>
              <entry colname="5">01.04.2013 </entry>
            </row>
            <row>
              <entry colname="1">Otezla </entry>
              <entry colname="2">Apremilast </entry>
              <entry colname="3">L04AA32 </entry>
              <entry colname="4">Revmatologiske- og hudsykdommer </entry>
              <entry colname="5">01.04.2015 </entry>
            </row>
            <row>
              <entry colname="1">Oluminant </entry>
              <entry colname="2">Baricitinib </entry>
              <entry colname="3">L04AA37 </entry>
              <entry colname="4">Revmatologiske sykdommer </entry>
              <entry colname="5">15.11.2016 </entry>
            </row>
            <row>
              <entry colname="1">Benepali </entry>
              <entry colname="2">Etanercept </entry>
              <entry colname="3">L04AB01 </entry>
              <entry colname="4">Revmatologiske- og hudsykdommer </entry>
              <entry colname="5">01.03.2016 </entry>
            </row>
            <row>
              <entry colname="1">Enbrel </entry>
              <entry colname="2">Etanercept </entry>
              <entry colname="3">L04AB01 </entry>
              <entry colname="4">Revmatologiske- og hudsykdommer </entry>
              <entry colname="5">01.06.2006 </entry>
            </row>
            <row>
              <entry colname="1">Erelzi </entry>
              <entry colname="2">Etanercept </entry>
              <entry colname="3">L04AB01 </entry>
              <entry colname="4">Revmatologiske- og hudsykdommer </entry>
              <entry colname="5">15.10.2016 </entry>
            </row>
            <row>
              <entry colname="1">Flixabi </entry>
              <entry colname="2">Infliksimab </entry>
              <entry colname="3">L04AB02 </entry>
              <entry colname="4">Revmatologiske-, hud- og mage-tarmsykdommer </entry>
              <entry colname="5">15.07.2016 </entry>
            </row>
            <row>
              <entry colname="1">Inflectra </entry>
              <entry colname="2">Infliksimab </entry>
              <entry colname="3">L04AB02 </entry>
              <entry colname="4">Revmatologiske-, hud- og mage-tarmsykdommer </entry>
              <entry colname="5">01.10.2013 </entry>
            </row>
            <row>
              <entry colname="1">Remsima </entry>
              <entry colname="2">Infliksimab </entry>
              <entry colname="3">L04AB02 </entry>
              <entry colname="4">Revmatologiske-, hud- og mage-tarmsykdommer </entry>
              <entry colname="5">01.10.2013 </entry>
            </row>
            <row>
              <entry colname="1">Remicade </entry>
              <entry colname="2">Infliksimab </entry>
              <entry colname="3">L04AB02 </entry>
              <entry colname="4">Revmatologiske-, hud- og mage-tarmsykdommer </entry>
              <entry colname="5">01.06.2006 </entry>
            </row>
            <row>
              <entry colname="1">Amgevita </entry>
              <entry colname="2">Adalimumab </entry>
              <entry colname="3">L04AB04 </entry>
              <entry colname="4">Revmatologiske-, hud- og mage-tarmsykdommer </entry>
              <entry colname="5">15.10.2016 </entry>
            </row>
            <row>
              <entry colname="1">Amhumgen </entry>
              <entry colname="2">Adalimumab </entry>
              <entry colname="3">L04AB04 </entry>
              <entry colname="4">Revmatologiske-, hud- og mage-tarmsykdommer </entry>
              <entry colname="5">15.10.2016 </entry>
            </row>
            <row>
              <entry colname="1">Humira </entry>
              <entry colname="2">Adalimumab </entry>
              <entry colname="3">L04AB04 </entry>
              <entry colname="4">Revmatologiske-, hud- og mage-tarmsykdommer </entry>
              <entry colname="5">01.06.2006 </entry>
            </row>
            <row>
              <entry colname="1">Cimzia </entry>
              <entry colname="2">Certolicumab pegol </entry>
              <entry colname="3">L04AB05 </entry>
              <entry colname="4">Revmatologiske sykdommer </entry>
              <entry colname="5">25.01.2010 </entry>
            </row>
            <row>
              <entry colname="1">Simponi </entry>
              <entry colname="2">Golimumuab </entry>
              <entry colname="3">L04AB06 </entry>
              <entry colname="4">Revmatologiske- og mage-tarmsykdommer </entry>
              <entry colname="5">08.12.2009 </entry>
            </row>
            <row>
              <entry colname="1">Kineret </entry>
              <entry colname="2">Anakinra </entry>
              <entry colname="3">L04AC03 </entry>
              <entry colname="4">Revmatologiske sykdommer </entry>
              <entry colname="5">01.06.2006 </entry>
            </row>
            <row>
              <entry colname="1">Stelara </entry>
              <entry colname="2">Ustekinumab </entry>
              <entry colname="3">L04AC05 </entry>
              <entry colname="4">Revmatologiske- og hudsykdommer </entry>
              <entry colname="5">01.08.2009 </entry>
            </row>
            <row>
              <entry colname="1">RoActemra </entry>
              <entry colname="2">Tocilizumab </entry>
              <entry colname="3">L04AC07 </entry>
              <entry colname="4">Revmatologiske sykdommer </entry>
              <entry colname="5">01.07.2014 </entry>
            </row>
            <row>
              <entry colname="1">Cosentyx </entry>
              <entry colname="2">Secukinumab </entry>
              <entry colname="3">L04AC10 </entry>
              <entry colname="4">Hudsykdommer </entry>
              <entry colname="5">01.04.2015 </entry>
            </row>
            <row>
              <entry colname="1">Brodalumab </entry>
              <entry colname="2">Brodalumab </entry>
              <entry colname="3">L04AC12 </entry>
              <entry colname="4">Hudsykdommer </entry>
              <entry colname="5">15.07.2016 </entry>
            </row>
            <row>
              <entry colname="1">Taltz </entry>
              <entry colname="2">Ixekizumab </entry>
              <entry colname="3">L04AC13 </entry>
              <entry colname="4">Hudsykdommer </entry>
              <entry colname="5">15.05.2016 </entry>
            </row>
            <row>
              <entry colname="1">Skilarence </entry>
              <entry colname="2">Dimetylfumarat </entry>
              <entry colname="3">N07XX09 </entry>
              <entry colname="4">Hudsykdommer </entry>
              <entry colname="5">15.11.2016 </entry>
            </row>
            <row>
              <entry colname="1">Nerventra </entry>
              <entry colname="2">Laquinimod </entry>
              <entry colname="3">N07XX10 </entry>
              <entry colname="4"/>
              <entry colname="5">01.10.2013 </entry>
            </row>
            <row>
              <entry colname="1">Xeljanz </entry>
              <entry colname="2">Tofacitinib </entry>
              <entry colname="3">L04AA29 </entry>
              <entry colname="4"/>
              <entry colname="5">01.01.2013 </entry>
            </row>
          </tbody>
        </tgroup>
      </table>
    </kapittel>
    <kapittel type="kapittel" id="/kapittel/ii" url="https://lovdata.no/lovtidend/forskrift/2016-10-11-1279/kii">
      <kverdi>II</kverdi>
      <ktittel/>
      <ledd id="/kapittel/ii/ledd/1">Forskriften trer i kraft 15. november 2016.</ledd>
    </kapittel>
  </tekst>
</dokument>
